Background: topographic correlation between the primary gastric tumor and the first peri-and extragastric lymphatic drain basin (solitary lymph node metastasis) on gastrectomy specimens, represents a reliable method to investigate and understand the exact pattern of lymphatic drainage from a gastric tumor. analyzing that correlation, useful information regarding the extent of the appropriate oncological perigastric lymphadenectomy will be provided. We retrospectively evaluate the usefulness of a modified d2 lymphadenectomy in gastric cancer patients, based on the topographic correlation between the primary tumor and the location of the solitary lymph node metastases, as they were detected by histology and immunohistochemistry.
the 60% of the histologically detected, 57% of the immunohistochemically detected and 59% of all solitary lymph node metastases. 80% of solitary metastases in the level ii ln stations, were mainly located in the nos 7-9 lymph node stations complex. tumors of the lower and middle-third of the stomach were equally drained both to the level i and level ii lymph node stations, while 67% of the tumors towards the lesser curvature, were mainly drained in the level ii lymph node stations.
Conclusion: d2 lymphadenectomy increases the number of true r0 resections. thus, a modified d2 lymphadenectomy should be routinely performed in gastric cancer patients.
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MATERiALS AnD METHoD
Between April 2003 and March 2010, 245 patients with a preoperative diagnosis of gastric adenocarcinoma, were subjected to surgery with curative intent, in our Department. in 134 among them, a modified D2 lymphadenectomy was offered as the standard surgical procedure. Patients with pathologically serosa-positive gastric cancer, (13) patients suffering from other types of gastric malignancies, patients who had undergone D1 lymphadenectomy as well as patients who were operated on for palliation, were excluded from the present study. none of the included patients had undergone preoperative chemotherapy or radiotherapy.
Postoperatively, the standard histological examination by hematoxylin and eosin (HE) staining, disclosed metastatic infiltration of at least two lymph nodes in the level i and/or ii peri-and extragastric lymph node stations in 90 patients. Solitary lymph node metastases were histologically detected in 10 patients, while the remaining 34 patients were classified as pn0.
All lymph nodes of the ten patients with histological solitary lymph node metastases were further submitted to immunohistochemistry for micrometastases detection.
All lymph nodes of the 34 patients who had been classified as pn0 by histology, were further submitted to immunohistochemistry for micrometastases detection.
The diagram of the study flow is presented in Table 1 .
SURGiCAL TECHniqUE
The proximal resection margin of the stomach was calculated according to the location of the primary tumor. A 6-cm tumor-free (based on the frozen section result) proximal resection margin from the most proximal macroscopic border (14) was achieved in all cases. Particularly in cases of upper and middle third gastric tumors, when the previous prerequisite was met, total gastrectomy was avoided (15) . The dissection of the regional lymph nodes (Ln) was based on the Japanese Classification of Gastric Carcinoma. (16) Thus, for D1 lymphadenectomy, the appropriate (depending on the location of the primary tumor) nos. 1-6 Ln stations were included in the gastrectomy specimen, whereas in the modified D2 lymphadenectomy, the nos. 7, 8a, 9, 11p, 11d and 12a Ln stations, were routinely dissected. The level ii lymph node stations were recognizable as they had inTRoDUCTion Histologically confirmed metastatic infiltration of peri-and extra-gastric lymph nodes has been defined as the strongest independent dismal prognostic factor for both early (1) and advanced (2) gastric cancer patients.
it could be proposed that by performing a D2 lymphadenectomy, coexisting micrometastases are resected (3), coexisting skip metastases and micrometastases are also resected (4), thus more R0 resections are achieved (5), facts probably leading to locoregional control of the disease, better outcome and increased survival (6). Thus, in order to avoid leaving undissected possibly metastatically infiltrated lymph nodes, surgeons commonly perform extended lymphadenectomies, even in cases of early gastric cancer tumors (7). D2 lymphadenctomy may control better the local lymph node metastasis comparing to the D1 surgery, but it carries statistically significant higher postoperative morbidity, mortality and reoperations rates (8). However, it has been proposed as unnecessary especially for patients without lymph node metastases (9).
Theoretically, with the application of the sentinel node navigation surgery concept in gastric cancer patients, minimally invasive surgery and personalized lymphadenectomy could be possible (10) . However, the clinical application of the technique disclosed that the clinical rate of lymph node metastases located in different lymphatic basin from the sentinel nodes detected, ranged between 10% and 37.5%, depending on the location of the primary tumor and the method used (11, 12) .
Thus, the only method to investigate and understand the exact pattern of lymphatic drainage from a gastric tumor is the topographic correlation between the primary tumor and the first peri-and extragastric lymphatic drain basin (solitary lymph node metastasis), on gastrectomy specimens. Analyzing that correlation, useful information regarding the necessity or not, as well as the extent of the appropriate oncological perigastric lymphadenectomy will be provided.
in the present retrospective study, we evaluate the usefulness of a modified D2 lymphadenectomy in gastric cancer patients, based on the topographic cor-been sent separately to the Pathology Department with special indices demonstrating their exact location. Dissection of the no 10 lymph node station, splenectomy or distal pancreatectomy was not performed in any of the patients. For staging of the tumors, the TnM classification system according to the AJCC Staging Manual, 7th edition, was used (17).
HiSToPATHoLoGy AnD iMMUnoHiSToCHEMiSTRy
Primary tumors and lymph nodes were fixed in formalin and embedded in paraffin. The presence or absence of lymph node metastasis was examined routinely by HE staining by using a representative cut section through the largest diameter of the lymph nodes.
one additional section of 4-μm thickness from each node was prepared for immunohistochemical staining with a monoclonal anti-cytokeratin (CK) antibody cocktail (AE1/ AE3; Dako, Glostrup, Denmark) that reacts with a broad spectrum of human CKs, to detect micrometastases and/or clusters of isolated tumor cells. Briefly, for AE1/AE3 immunostaining, paraffin-embedded sections were deparaf-finized in xylene and rehydrated through graduated ethanol to water. Endogenous peroxxidase activity was blocked by incubation for 30 min with a solution of 1% hydrogen peroxxide, and antigen retrieval was performed by autoclaving sections in 0.01 mol/L citrate buffer, pH 6.0 for 20 min at 800 W. A monoclonal mouse anti-human CK antibody (clone AE1/AE3) was applied at a dilution of 1:50. The Dako Real Envision kit was then used. Diaminobenzidine was used as a chromogen. Lymphoid tissue was used as an internal negative control, while additional sections from the primary tumors were used as positive controls.
RESULTS
Among the lymph nodes of the ten patients with histological solitary lymph node metastases which were further submitted to immunohistochemistry for micrometastases detection, no micrometastases were disclosed.
Among the lymph nodes of the 34 patients who had been classified as pn0 by histology and were further submitted to immunohistochemistry for mi- crometastases detection, more than one micrometastases were detected in none of them, while in three patients micrometastases were detected in the level i perigastric lymph nodes stations and in additional four patients micrometastases were detected in the level ii extragastric lymph nodes stations (skip micrometastases). overall, solitary lymph node metastases were detected by histology in ten patients and by immunohistochemistry in additional seven. There were nine females with a median age of 64 years (iR 56-80) and eight males with a median age of 67 years (iR 63-70). The profile of the patients included in the study, is presented in Table 2 .
Solitary metastases were detected in the level i Ln stations in seven patients (four by histology and three by immunohistochemistry) and in the level ii Ln stations in ten patients (six by histology and four by immunohistochemistry). in order of frequency, the solitary lymph node metastases were located in the no 7 (n = 6), no 6 (n = 4), no 9 (n = 2), no 5 (n = 2), no 4 (n = 1), no 8 (n = 1) and no 12 (n = 1) Ln stations. (Figure 1) The above findings addressed that the incidence of the histologically detected solitary lymph node metastases was 7.5% for the whole population (10 out of 134), while this incidence increased to 12.7% (17 out of 134) with the use of immunohistochemistry.
The incidence of the histologically detected skip solitary lymph node metastases was 4.5% for the whole population (six out of 134), while this incidence increased to 7.5% (ten out of 134) with the use of immonohistochemistry. Skip metastases encountered the 60% (six out of ten) of the histologically detected, 57% (four out of seven) of the immunohistochemically detected and 59% (ten out of 17) of all solitary lymph node metastases.
Solitary metastases in the level i Ln stations, were mainly located along the greater curvature (five out of seven patients), while solitary metastases in the level ii Ln stations, were mainly located in the nos 7-9 Ln stations complex (eight out of ten patients).
Especially for patients with T1-2 tumors (n = 13), solitary lymph node metastases were detected in the level ii Ln stations in nine of them, mainly in the no 7-9 Ln station complex (eight out of nine).
Tumors towards the lesser curvature, were mainly drained in the level ii Ln stations (eight out of 12), while tumors towards the grater curvature were mainly drained in the level i Ln stations (three out of three).
Tumors of the lower third of the stomach were equally drained both to the level i (four out of eight) and level ii (four out of eight) Ln stations. Tumors of the middle third of the stomach were also equally drained both to the level i (three out of seven) and level ii (four out of seven) Ln stations. 
DiSCUSSion
The results of the present study addressed that the incidence of the histologically detected solitary lymph node metastases in gastric cancer patients was 7.5%, while this incidence increased to 12.7% with the use of immunohistochemistry. The 7th TnM classification (17) clearly states that micrometastasis (n1mi) is defined as a metastatic focus no larger than 0.2 cm, which is detected by morphological techniques. Serial sectioning, reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemical staining, have been used for the identification of micrometastases. Among them, only immunohistochemical technique with human anticytokeratin antibodies represents the most accurate method for micrometastasis detection (18) and the commonest applied technique in research (19) .
The first issue emerging from the results of the present study, regards the clinical significance of the micrometastases. Although other reports (20) (21) failed to show any relationship between micrometastases presence and recurrence rate or outcome, Cai et al (22) reported a 5-year survival of 100% for the micrometastasis negative, compared to an 85% for the micrometastasis positive sm gastric cancer patients, Maehara et al (23) reported a 50% shorter survival for the micrometastases positive, compared to the micrometastases negative, early gastric cancer patients who died from recurrence of the disease, while Saito et al (24) reported presence of micrometastases in 50% of the early gastric cancer patients who presented with recurrence of the disease having been classified as pn0 on the initial conventional histology. Finally, experimental data (25) addressed that micrometastase in lymph nodes have high proliferative activity, thus potentially can develop metastases. Based on the above, undoubtedly micrometastases cannot be ignored.
The present study also addressed that more than half of the solitary lymph node metastases (60% of the histologically detected and 57% of the immunohistochemically detected), were skip metastases.
Another issue emerging from the results of the present study, regards the clinical significance of the skip metastases and micrometastases.Their clinical significance remains controversial and the controversies are mainly related to the small number of patients enrolled in skip metastasis studies (3), the probably different prognosis of patients with histologically versus micrometastatically detected skip metastases (18) , and the concern that the patients with histologically detected skip metastasis may represent cases of overlooked histological metastasis or micrometastasis in level i lymph nodes; thus being misclassified as patients with skip metastasis (26) .
Saito et al (26) comparing gastric cancer patients with skip metastasis to patients with metastasis in the level i and in the level ii lymph nodes, concluded that both the clinicopathological characteristics as well as the prognosis of patients with skip metastasis were similar to patients with level i lymph node metastases, but not to patients with level ii lymph node metastases. Li et al (9) reported that the cumulative survival rate was not statistically different between gas-tric cancer patient with solitary skip lymph node metastases, compared to patients with solitary level i lymph node metastases. Park et al (3) reported that in patients with positive nodes extending into the level ii lymph nodes, the survival curves did not show statistical differences between skip(+) and skip(-) groups of patients, further supporting the theory that the number but not the level of lymph node metastases has prognostic significance. However, we have previously reported (4) that skip micrometastases were immunohistochemically detected in 17% of T1-2 gastric cancer patients.
The present study also disclosed that 35% (6 out of 17) of the solitary lymph node metastases were detected in the no 7 Ln station, 80% (8 out of 10) of the skip solitary lymph node metastases were detected in the nos 7-9 Ln stations complex, while in patients with T1-2 gastric cancer tumors solitary lymph node metastases were detected in the nos 7-9 Ln stations complex in 61.5% among them (8 out of 13).
A third issue emerging from the results of the present study regards the clinical significance of the metastatic infiltration of the nos 7&9 Ln stations complex.
it has been proposed that the most likely route for para-aortic lymph node metastases is from the left gastric artery nodes, passing by the celiac artery (27) .Thus, these lymph nodes should be always evaluated, regardless the mode of operation, even in cases of minimally invasive surgery. yanagita et al (28) investigating the clinical significance of the morphological distribution of metastatic foci (metastasis, micrometastasis or isolated tumor cells) in sentinel lymph nodes with gastric cancer, concluded that in patients with nonmarginal sinus type sentinel node metastasis, attention should be paid to the possibility for non sentinel node or even pn2 metastases presence. Thus, if the sentinel node cannot be identified in the perigastric lymph nodes, the around the celiac artery lymph nodes should be explored to reduce the likelihood of false negative results in sentinel node mapping (29) .
Traditionally, a study on the lymphatic stream from gastric tumours was based on the classification of them as tumors of the upper, middle and lower third of the stomach. According to this classification, the nos 1 and 3 Ln stations were the most common first metastasized stations in upper-third tumors, the nos 3, 4 and 6 Ln stations were metastasized more frequently than other stations in lower and middle-third tumors (30, 31) , while 75-90% of the solitary lymph node metastases were located in the perigastric (level i) lymph node area (7, 9, 32) .
The present study however, disclosed that in only 47% (7 out of 15) of the lower and middle-third gastric tumors, solitary lymph node metastases were located in the level i lymph node area. Moreover, classifying the primary gastric tumors as those towards the lesser curvature and those towards the grater curvature, the present study disclosed that the former group was mainly drained (67%, 8 out of 12) in the level ii lymph node area. However, no reliable conclusion can be made, since the data size is extremely small. D2 lymphadenectomy did not gain popularity in the West, since prospective randomized studies (33) (34) (35) (36) (37) and meta-analysis (38) revealed statistically significant higher postoperative morbidity and mortality rates (mainly related to the surgical technique) and no 5-years and 11-years survival benefit compared to the D1 lymphadenectomy. only one study (8) disclosed that after a median follow-up of 15 years, D2 lymphadenectomy was associated with lower locoregional recurrence and gastric-cancer-related death rates, compared to D1 surgery.
Since in 88% of the patients (15 out of 17), a true R0 resection can be achieved by the inclusion in the dissected bed only the nos 7&9 Ln stations complex, a technique which obviously carries less perioperative morbidity, someone could consider D1+ lymphadenectomy as enough for the treatment of gastric cancer. However, we consider the remaining 12% as high enough, thus we propose the modified D2 lymphadenectomy as the only technique which can lead to locoregional control of the disease in a higher proportion of patients.
in conclusion, the results of the present study address that D2 lymphadenectomy increases the number of true R0 resections. Thus, a modified D2 lymphadenectomy should be routinely performed in gastric cancer patients.
